ZipurskyJ, JuurlinkDN. The implausibility of neonatal opioid toxicity from breastfeeding. Clin Pharmacol Ther, 2020; 108(5):964–970.
2.
KorenG, CairnsJ, ChitayatD, et al.Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother. Lancet, 2006; 368(9536):704.
3.
WillmannS, EdgintonAN, CoboekenK, et al.Risk to the breast-fed neonate from codeine treatment to the mother: A quantitative mechanistic modeling study. Clin Pharmacol Ther, 2009; 86(6):634–643.
4.
TsuyukiRT, PimlottN. Risks of maternal codeine intake in breast-fed infants: A joint statement of retraction from the Canadian Pharmacists Journal and Canadian Family Physician. Can Pharm J (Ott), 2021; 154(1):7–8.
5.
PimlottN, TsuyukiRT. Risks of maternal codeine intake in breastfed infants: A joint statement of retraction from Canadian Family Physician and the Canadian Pharmacists Journal. Can Fam Physician, 2020; 66(11):793–796.
6.
The Editors Of The Lancet. Expression of concern: Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother. Lancet, 2026; 407(10529):659.
7.
TaubB. A fatal error. The New Yorker, 2026; 6:28–39.
8.
HalderS, RussellR, QuinlanJ. Codeine and breast-feeding mothers. Int J Obstet Anesth, 2015; 24(1):5–7.
9.
ZipurskyJS, GomesT, EverettK, et al.Maternal opioid treatment after delivery and risk of adverse infant outcomes: Population based cohort study. BMJ, 2023; 380:e074005.
10.
NautaM, LandsmeerML, KorenG. Codeine-acetaminophen versus nonsteroidal anti-inflammatory drugs in the treatment of post-abdominal surgery pain: A systematic review of randomized trials. Am J Surg, 2009; 198(2):256–261.
11.
ItoS. Opioids in breast milk: Pharmacokinetic principles and clinical implications. J Clin Pharmacol, 2018; 58,(Suppl 10):S151–S163.
